MedTrace Logo

IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE

NCT07521202 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 257

Last updated 2026-04-09

No results posted yet for this study

Summary

The goal of this interventional study is to evaluate the effect of standardized patient coaching on treatment adherence among patients taking abemaciclib.

The main question it aims to answer is, whether standardized coaching leads to patients taking abemaciclib much more consistently. Researchers will therefore compare therapy adherence of patients receiving standardized coaching to patients receiving routine care.

Participants will be asked to answer several questionnaires.

Conditions

  • HR+/HER2- Early Breast Cancer

Interventions

BEHAVIORAL

Standardized patient coaching

Standardized patient coaching based on the Multinational Association of Supportive Care in Cancer (MASCC) Oral Agent Teaching Tool© (MOATT)

Sponsors & Collaborators

  • Lilly Deutschland GmbH Germany

    collaborator UNKNOWN

  • Institut fuer Frauengesundheit

    lead OTHER

Principal Investigators

  • Peter A. Fasching, Prof. Dr. med. · Department of Obstetrics and Gynaecology, Uniklinikum Erlangen

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2029-06-30
Completion
2030-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07521202 on ClinicalTrials.gov